Drug Profile
Escherichia coli vaccine - Emergent BioSolutions
Alternative Names: ETEC vaccine - Emergent BioSolutions; Traveller's diarrhoea vaccine - Emergent BioSolutionsLatest Information Update: 20 Oct 2021
Price :
$50
*
At a glance
- Originator Emergent BioSolutions
- Class Escherichia coli vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Escherichia coli infections
Most Recent Events
- 10 Nov 2010 Discontinued - Phase-I for Escherichia coli infections in United Kingdom (PO)
- 07 Mar 2006 This vaccine is available for licensing (http://www.ebse.com)
- 27 Jun 2005 Microscience has been acquired by Emergent BioSolutions